Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lasmiditan for Acute Migraine in Japanese Patients
NCT03962738Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lasmiditan in migraine, sponsored by Eli Lilly and Company. Started May 2019; status: completed.
02
Drugs
lasmiditan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03962738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962738.